Kahvejian Avak, Quackenbush John, Thompson John F
Helicos BioSciences, One Kendall Square, Cambridge, Massachusetts 02139, USA.
Nat Biotechnol. 2008 Oct;26(10):1125-33. doi: 10.1038/nbt1494.
It could be argued that the greatest transformative aspect of the Human Genome Project has been not the sequencing of the genome itself, but the resultant development of new technologies. A host of new approaches has fundamentally changed the way we approach problems in basic and translational research. Now, a new generation of high-throughput sequencing technologies promises to again transform the scientific enterprise, potentially supplanting array-based technologies and opening up many new possibilities. By allowing DNA/RNA to be assayed more rapidly than previously possible, these next-generation platforms promise a deeper understanding of genome regulation and biology. Significantly enhancing sequencing throughput will allow us to follow the evolution of viral and bacterial resistance in real time, to uncover the huge diversity of novel genes that are currently inaccessible, to understand nucleic acid therapeutics, to better integrate biological information for a complete picture of health and disease at a personalized level and to move to advances that we cannot yet imagine.
可以说,人类基因组计划最具变革性的方面并非基因组本身的测序,而是由此带来的新技术发展。一系列新方法从根本上改变了我们在基础研究和转化研究中解决问题的方式。如今,新一代高通量测序技术有望再次改变科学事业,有可能取代基于阵列的技术并开辟许多新的可能性。通过使DNA/RNA的检测速度比以往更快,这些新一代平台有望让我们对基因组调控和生物学有更深入的理解。显著提高测序通量将使我们能够实时追踪病毒和细菌耐药性的演变,揭示目前难以获取的大量新基因的多样性,理解核酸治疗方法,在个性化层面更好地整合生物信息以全面了解健康和疾病,并迈向我们尚未想象到的进步。